MicroVention-Terumo, Inc.
Clinical trials sponsored by MicroVention-Terumo, Inc., explained in plain language.
Medical device company specializing in neurovascular and endovascular therapies, owned by Terumo.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New catheter could improve stroke recovery
Disease control Not yet recruitingThis study tests a new device, the SOFIA Flow 88 Aspiration Catheter, to treat acute ischemic stroke caused by a large blocked artery. About 200 adults with moderate to severe stroke will be enrolled. The goal is to safely restore blood flow to the brain using only this catheter,…
Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Liquid embolization may offer Needle-Free alternative to brain surgery for blood clots
Disease control Not yet recruitingThis study tests a new approach for treating chronic subdural hematoma (a blood clot on the brain) using a liquid called PHIL™ that is injected into the middle meningeal artery to block blood flow to the clot. The trial will compare this minimally invasive procedure to standard s…
Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC